Officials Cast Doubt on a Dementia Drug, but Human Trials Continuenews2024-10-02T19:41:40+00:00October 2nd, 2024|The New York Times|
El ‘médico rural’ que transformó nuestra manera de ver la demencianews2024-09-14T09:03:22+00:00September 14th, 2024|The New York Times|
Francisco Lopera, the ‘Country Doctor’ Who Upended Our Understanding of Dementianews2024-09-11T14:07:34+00:00September 11th, 2024|The New York Times|
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?news2024-06-17T21:59:44+00:00June 17th, 2024|The New York Times|
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefitsnews2024-06-10T09:00:35+00:00June 10th, 2024|The New York Times|
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’snews2024-05-06T16:19:15+00:00May 6th, 2024|The New York Times|
¿Se puede tener alzhéimer y no presentar síntomas?news2024-03-06T15:35:15+00:00March 6th, 2024|The New York Times|
Apparently Healthy, but Diagnosed With Alzheimer’s?news2024-03-04T17:25:50+00:00March 4th, 2024|The New York Times|
What to Know About Mild Cognitive Impairment Treatmentnews2024-02-06T17:44:41+00:00February 6th, 2024|The New York Times|
